Business Description
Attana AB
ISIN : SE0010547273
Share Class Description:
NGM:ATANA: Ordinary SharesTotal Employee Number:
6Compare
Compare
Traded in other countries / regions
ATANA.Sweden IPO Date
2018-03-07Description
Attana AB offers biologically relevant information to improve efficiency and performance of pharmaceutical drug development.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.31 | |||||
Beneish M-Score | -2.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -56.3 | |||||
3-Year EBITDA Growth Rate | 52.8 | |||||
3-Year EPS without NRI Growth Rate | 50 | |||||
3-Year FCF Growth Rate | 49.3 | |||||
3-Year Book Growth Rate | -42.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.76 | |||||
9-Day RSI | 47.39 | |||||
14-Day RSI | 47.63 | |||||
3-1 Month Momentum % | -25 | |||||
6-1 Month Momentum % | -40 | |||||
12-1 Month Momentum % | -73.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.78 | |||||
Quick Ratio | 0.33 | |||||
Cash Ratio | 0.05 | |||||
Days Sales Outstanding | 100.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -88.6 | |||||
Shareholder Yield % | -37.15 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 158.11 | |||||
Operating Margin % | -910.82 | |||||
Net Margin % | -938.46 | |||||
EBITDA Margin % | -702.82 | |||||
FCF Margin % | -743.49 | |||||
OCF Margin % | -599.54 | |||||
ROE % | -63.97 | |||||
ROA % | -51.54 | |||||
ROIC % | -55.55 | |||||
3-Year ROIIC % | -57.64 | |||||
ROC (Joel Greenblatt) % | -834.45 | |||||
ROCE % | -56.46 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4 | |||||
PB Ratio | 1 | |||||
EV-to-EBIT | -1.53 | |||||
EV-to-EBITDA | -1.99 | |||||
EV-to-Revenue | 13.99 | |||||
EV-to-Forward-Revenue | 3.71 | |||||
EV-to-FCF | -1.88 | |||||
Earnings Yield (Greenblatt) % | -64.94 | |||||
FCF Yield % | -59.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Attana AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 1.313 | ||
| EPS (TTM) (kr) | -0.004 | ||
| Beta | -3.3766 | ||
| 3-Year Sharpe Ratio | 0.09 | ||
| 3-Year Sortino Ratio | 0.26 | ||
| Volatility % | 58.75 | ||
| 14-Day RSI | 47.63 | ||
| 14-Day ATR (kr) | 0.000992 | ||
| 20-Day SMA (kr) | 0.004425 | ||
| 12-1 Month Momentum % | -73.91 | ||
| 52-Week Range (kr) | 0.003 - 0.0175 | ||
| Shares Outstanding (Mil) | 4,128.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Attana AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Attana AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-10-30 | In 119 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | In 49 days | ||
| General meeting for 2025 | 2026-07-03 | 0.00 (+33.33%) | ||
| First quarter earnings results for 2026 | 2026-05-29 | 0.00 (-14.29%) | ||
| Annual report for 2025 | 2026-05-01 | 0.00 (+16.67%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-27 | 0.01 (+37.50%) | ||
| Third quarter earnings results for 2025 | 2025-10-31 | 0.01 (+10.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-22 | 0.02 (+0.00%) | ||
| Annual report for 2024 | 2025-05-21 | 0.02 (-17.14%) | ||
| First quarter earnings results for 2025 | 2025-05-09 | 0.01 (-12.50%) |
Show
Entries
Attana AB Frequently Asked Questions
What is Attana AB(NGM:ATANA)'s stock price today?
The current price of NGM:ATANA is kr0.00. The 52 week high of NGM:ATANA is kr0.02 and 52 week low is kr0.00.
When is next earnings date of Attana AB(NGM:ATANA)?
The next earnings date of Attana AB(NGM:ATANA) is 2026-08-21 Est..
Does Attana AB(NGM:ATANA) pay dividends? If so, how much?
Attana AB(NGM:ATANA) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Significant progress made in new COVID-19 vaccine developed by the team of Prof Salanti | 2021-01-13 | ||
| Release of Initial Attana Virus Analytics-AVA Testing Protocols | 2020-06-30 |
Articles on Attana AB
No articles.